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ABSTRACT 
Objective: The aim of present study was to develop and evaluate mucoadhesive microbeads for oral sustained release of an antiasthmatic agent 
“theophylline” using natural gums such as sodium alginate and sesbania gum.  
Methods: The compatibility studies of drug with different polymers were investigated by using DSC (Differential Scanning Calorimeter) and FTIR 
(Fourier Transform Infrared Spectroscopy). Carbohydrate heteropolymer microbeads of alginate and sesbania gums were prepared by ionotropic 
gelation technique, where calcium chloride is used as a source of counter ions. Prepared beads were characterized for particle size, entrapment 
efficiency, surface morphology, swelling index, in vitro release studies and release kinetics.  
Results: Final optimized formulation consists of a polymer blend of alginate and sesbania gum with hydroxy propyl cellulose as release modifier. 
Microbeads exhibited good swelling index and high percentage of drug entrapment efficiency. The developed formulation showed a maximum drug 
release of 92% in 11 h using 0.1 N hydrochloric acid buffer (pH 1.2). The formulation followed Korsmeyer-Peppas and Higuchi release mechanism, 
releasing the drug by non-fickian diffusion. Prepared beads showed significant mucoadhesion in acidic buffer.  
Conclusion: The sustained release microbeads were successfully designed for oral administration of theophylline which may be used for the 
treatment of nocturnal asthma. 
Keywords: Mucoadhesive, Natural polymers, Microbeads, Sustained release, Theophylline. 
 
INTRODUCTION 
CRSs (Controlled release systems) have been extensively 
developed due to their considerable therapeutic advantages over 
conventional forms [1]. The development of CRSs using natural 
hydrophilic polymers becoming popular as these offer various 
desired characteristics such as cost-effectiveness, safety, non-
toxicity, biocompatibility and biodegradability of a drug delivery 
matrix. Furthermore, these polysaccharides can be conveniently 
tailored using chemical or biochemical tools to develop a drug 
delivery matrix with specific features, hence, have been 
extensively studied in medicine and pharmaceutical laboratories. 
The polymeric hydrogels are three-dimensional cross-linked 
networks that are able to absorb water and swell without losing 
their shape. One of the mostly used natural polysaccharide as drug 
carrier is sodium alginate, which undergoes a sol-gel 
transformation in response to divalent cations. Alginate is 
preferably used to prepare multi-unit controlled release dosage 
forms like microbeads and micro particles which spread over a 
large surface area preventing exposure of the absorbing site to 
high drug concentration on chronic release. These microbeads 
may be dispensed as filled in hard gelatin capsules or they can be 
compressed into tablets [2]. These microbeads are usually 
prepared by using polyelectrolyte complexes of alginate with 
other polymers as if used alone, it shows unsatisfactory drug 
release profiles. In the present study, sesbania gum is used with 
alginate as polymer matrix, which is obtained from the endosperm 
of Sesbania bispinosa seeds, family Leguminosae. It consists of a 
linear chain of (1, 4)-β-D-mannopyranose units with α-D-galacto-
pyranose units attached by (1-6) linkages, the ratio of mannose to 
galactose is 2:1 [3]. The alginate-sesbania gum polymer was used 
only for the entrapment of theophylline, a bronchodilator used as 
an add-on therapy to low or high doses of inhaled 
glucocorticosteroids for asthma control [4]. The short biological 
half–life (about 3.5 h) of theophylline requires to be delivered as 
controlled release systems [5]. The use of sesbania gum along with 
alginate enhanced the entrapment efficiency and sustains release 
of theophylline.  
MATERIALS AND METHODS 
Chemicals 
Theophylline was kindly gifted from French Pharma, Chandigarh, 
India. Sodium alginate be procured from CP Kelco Pvt. Ltd, Mumbai, 
India. Sesbania gum was a generous gift by Govind Madhav 
Industries, Mehsana, India. Hydroxy Propyl Cellulose and other 
buffer salts were purchased from LobaChemie Pvt. Ltd, Mumbai, 
India. Thimerosal was supplied from Alpha Chemika, Mumbai, India.  
Methodology 
Analytical method development and validation 
The quantitative and qualitative determination of theophylline was done 
using a double beam UV-visible spectrophotometer (Shimadzu, Japan). 
The theophylline was dissolved in 0.1 N HCl buffer (pH 1.2) and the 
absorption spectrum was recorded. A calibration curve was drawn by 
plotting concentrations of theophylline ranging from 1-8 µl/ml on X-axis 
and their corresponding absorbance on Y-axis. The method was 
validated in terms of linearity, precision, accuracy and robustness.  
Drug-polymer compatibility studies 
Drug–polymer interactions were confirmed using FT-IR 
spectroscopy. The drug was mixed separately with sodium alginate 
and sesbania gum in 1:1 ratio, filled in separate glass vials and then 
stored under three different conditions, 8 °C±2 °C,25 °C±2 °C and 40 
°C±2 °C with 75% RH in a humidity chamber for one month. Vials 
containing pure drug and pure polymers were also kept in similar 
conditions. Samples were taken on 0, 7, 15 and 30th day and 
prepared in potassium bromide disk (2 mg sample in 200 mg KBr) 
with a hydraulic press by applying a pressure of 8-9 tons for 2 min. 
The discs were scanned over a wave number range of 4000-400 cm-1 
and the resolution was kept at 4 cm-1. 
Development of formulation 
Initially the microbeads of sodium alginate were prepared by 
ionotropic cross linking method [6]. Sodium alginate and dispersed 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 7, Issue 7, 2015 
Innovare 
Academic Sciences 
Singh et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 7, 295-299 
296 
in distilled water at 60 °C with stirring using glass rod. Theophylline 
(400 mg) was dissolved and dispersed in the above prepared 
polymer solution after lowering the temperature upto 20 °C. 
Thiomersal (0.5 mg) as preservative was also added in the above 
mixture. This bubble free solution (5 ml) was dropped through 21 G 
needles into chilled calcium chloride solution (10 %) with stirring at 
100 rpm on magnetic stirrer to form the gelled beads. The beads 
were allowed to cure for 3 h in the calcium chloride solution and 
then separated by filtration, washed thrice with distilled water and 
kept in a hot air oven at 40 °C for drying. For preparation of alginate-
sesbania microbeads, varied concentrations of sesbania gum were 
blended a selected concentration of sodium alginate and then. 
Similar procedure was followed.  
Differential scanning calorimetry (DSC) 
Thermograms of pure theophylline and the polymer blends were 
recorded using a DSC (DSC 8500, Perkin Elmer, Maharashtra, India). 
Each sample (3–4 mg) was accurately weighed into an aluminium 
pan in a hermetically sealed condition. The measurements were 
performed in an atmosphere of nitrogen (20 ml/min) between 30–
500 °C at a heating rate of 10 °C/min. 
Determination of % yield 
The % yield of all the formulations of microbeads was calculated 
using the following formula:  
% Yield =
Total weight of dried microbeads
Total weight of polymer + drug
 × 100 
Estimation of drug entrapment efficiency 
The amount of theophylline present in the filtrate after bead 
formation was measured and subtracted from the total amount 
taken initially to determine total entrapped drug. The drug 
entrapment efficiency (%) was calculated using the following 
formula:  
% Entrapment efficiency =  
(Total drug− Drug in filtrate)
Total drug
 × 100 
Micromeritic properties of microbeads 
Various micromeritic properties such as particle size analysis, bulk 
density, tapped density, angle of repose etc. were assessed for the 
prepared beads using standard protocols. Particle size analysis was 
performed by optical microscopy using a compound microscope 
(Kyowa, Japan). Angle of repose was measured according to the 
“fixed funnel and free standing cone method”. % compressibility 
index and Hausner’s ratio were also calculated using standard 
formulae.  
Equilibrium swelling studies  
10 mg of microbeads were placed in 0.1 N HCl buffer (pH 1.2) and 
allowed to swell up to a constant weight. After this the microbeads 
were removed, blotted with filter paper and their change in weight 
was measured. The swelling index was then calculated from the 
following formula:  
Swelling index (%) =  
Wet weight− Dry weight
wet weight
 × 100 
In vitro drug release study 
The drug release from alginate-sesbania microbeads was studied 
using a conventional USP type-II dissolution apparatus (Lab India 
Disso 2000, India) using 900 ml 0.1N HCl buffer (pH 1.2) at 37 °C for 
12 h. A sample (10 ml) was collected from dissolution test apparatus 
hourly and replaced with fresh buffer. The samples were diluted to 
suitable concentration with HCl buffer and assayed 
spectrophotometrically at 272 nm. 
In vitro release kinetics 
To investigate the drug release mechanism, in vitro release data was 
fitted with various release models such as Zero order, First order, 
Korsmeyer Peppas and Higuchi model. Regression coefficient values 
for all the release models were calculated and higher regression 
coefficient (>0.98) was considered as the validity of the model. The 
equations used for these kinetic models are listed below:  
Qt = kot(zero order) 
Log C = Log Co–kt/2.303 (first order) 
Qt = kH t1/2(Simplified Higuchi diffusion) 
Mt/M∞ = Ktn(Korsmeyer-Peppas equation) 
Where, 
Qt = amount of drug released at time (t),  
k0 = zero order release constant  
C = cumulative percent of drug release  
Co = the initial concentration of drug 
kH= Higuchi-diffusion rate constant,  
Mt/M∞ = fraction of drug released at time (t),  
K = constant comprising the structural and geometric characteristics 
of the microbeads 
n = release exponent  
Shape and surface morphology of microbeads 
Shape and surface characteristics of microbeads were investigated 
using scanning electron microscopy (SEM, Hitachi S 3400 N, Japan) 
of the samples before and after carrying out the dissolution. The 
SEM samples were prepared by lightly spreading the microbeads on 
carbon tape, which was stucked on an aluminium stub. The stubs 
were coated with gold using a gold sputter coater in a high vacuum 
evaporator, and the samples were observed at 10 kV. 
Mucoadhesion testing  
The mucoadhesive properties of various formulations of 
theophylline loaded alginate-sesbania beads were evaluated by the 
in vitro wash-off method. Freshly excised pieces of goat gastric 
mucosa [1 cm×1 cm, collected from a slaughter house (permission 
for the same was taken from Institutional Animal Ethical 
Committee)] were mounted on a glass slide using thread. About 50 
beads were spread out on each piece of mucosa and then hung from 
the arm of the tablet disintegration test apparatus. The tissue 
specimen was given a regular up and down movement in a 1 l vessel 
containing 900 ml of 0.1 N HCl (pH 1.2), maintained at 37±0.5 °C. 
The adherence of beads was regularly observed. The beads that 
remained adhered to the mucosa were counted at regular intervals 
for up to 10 h and % bioadhesion was calculated as:  
 
% Bioadhesion =
No. of microbeads adhered at a time interval "t"
Total no. of microbeads taken
× 100 
 
RESULTS AND DISCUSSION  
Physical description of drug 
Theophylline powder was creamy white in color, odorless and bitter in 
taste. It showed melting point in the range of 270-274 °C which was 
close to the reported value, i.e. 272.19 °C (Drug bank, 2012). The 
purity of the drug was further confirmed by FT-IR spectroscopy. 
Vibrational bands present>3000 cm-1 in the FTIR spectra of xanthine 
were assigned as N–H stretching of the imidazole ring. The other two 
bands present in the region at 2983-3121 cm-1 were assigned to N–H 
asymmetric and symmetric stretching. Strong bands observed at 1666 
cm-1 and at 1566 cm-1 in FTIR spectra were considered to be due to 
C=O asymmetric and symmetric stretching vibrations. Theophylline 
presented an intense absorbing stream around the frequency 1566 
cm-1, Stream that appears due to the C=N stretching vibrations. Similar 
observations have also been reported by Forizs et al. [7]. 
Analytical method development and validation 
The absorption maximum (λmax) of theophylline in HCl buffer (pH 
1.2) was found to be 272 nm which was good agreement with the 
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previously reported literature (271 nm, Patel et al., 2011). The 
standard curve of theophylline showed regression coefficient (R2) as 
0.9978 with the line equation of y= 0.118x+0.0004. The method 
developed was found to be accurate, precise and robust as the 
calculated R. S. D. values were less than 2. Intra-day and inter-day 
precision studies revealed that the method gives repeatedly the 
same results irrespective to the day and time of study. 
Drug-polymer compatibility studies 
Drug-polymer interactions were studied as described in methodology. 
During this study, no physical change in any of the mixture was 
observed. The samples were further checked by FT-IR spectroscopy. FT-
IR spectra of the drug and polymer combination showed the bands 
around 3448, 1666, 1425 and 1049 cm−1, indicating the stretching of 
O−H, COO− (asymmetric), COO− (symmetric) and C −O−C, respectively. 
All these bands were corresponding to sodium alginate [8]. The 
characteristic peaks of theophylline were observed at 1666, 1568 and 
3120 cm-1corresponding to the carbonyl group stretching, vibration of 
the pyrimidine ring and asymmetric aliphatic CH2, respectively. Identical 
peaks were also observed in FT-IR spectra of drug+polymer blend which 
indicated that no major interaction occurred between the functional 
groups of the studied drug and polymer blend upon mixing [7]. 
Development and evaluation of formulation 
Alginate-sesbania microbeads were developed following the 
procedure mentioned in the methodology section. The basic aim of 
formulation development was to enhance the overall yield of beads 
formation, drug entrapment in the beads, complete release of the 
entrapped drug with extended release time. The yield of beads 
formation and entrapment efficiency was calculated as described in 
the methodology section. The release profile of the drug was observed 
through in-vitro release studies using standard dissolution apparatus 
USP type-II. Table 1 represents compositions of polymers used in 
formulations along with their % yield, drug entrapment efficiency (%) 
and maximum release (%) of the drug along with the time required for 
maximum release. 
  









% Yield  Drug entrapment efficiency (%) Maximum drug release (%) 
F-1 1 - - - 72.50 68.63 - 
F-2 2 - - - 75.00 74.00 - 
F-3 3 - - - 77.25 77.25 81.2 (8 h) 
F-4 4 - - - 80.80 81.75 83.8 (9 h) 
F-5 5 - - - 81.20 80.63 83.6 (10 h) 
F-6 4 1 - - 81.57 81.86 79.1 (10 h) 
F-7 4 2 - - 82.05 83.65 74.7 (10 h) 
F-8 4 3 - - 85.61 87.33 72.07 (11 h) 
F-9 4 4 - - 85.50 87.00 68.3 (11 h) 
F-10 4 3 1 - 84.25 87.15 66.46 (12 h) 
F-11 4 3 - 1 86.33 87.55 86.3 (11 h) 
F-12 4 3 - 2 88.30 92.75 92 (11 h) 
F-13 4 3 - 3 88.25 87.34 87.2 (11 h) 
 
F1 to F5 consisted of only alginate gum in varying concentrations as 
microbeads forming matrix, whereas the F6 to F9 were made up of 
alginate-sesbania gun blend. As evident from the table 1, with 
increasing concentration of the support matrices, the yield and drug 
entrapment efficiency increased, along with the time of maximum 
drug release. For alginate microbeads, the loading efficiency and 
drug entrapment efficiency increased with increasing concentration 
of alginate up to 4% (w/v, F4), after that, no significant change was 
observed. In this formulation (F4), 83.8 % of the entrapped drug was 
released in 9 h. After blending with increasing concentrations of 
sesbania gun (F6-F9), the yield, entrapment efficiency and release 
time increased but the maximum drug release (%) decreased. This 
was expected, since on increasing sesbania gum concentration, 
interaction between two polymers had increased, forming a closer 
network, which decreased the diffusion of the drug outwards from the 
interior of the microbeads [8, 9]. The F8, consisting of 3% sesbania 
gum with 4% alginate showed good drug entrapment efficiency 
(87.33%) with extended release time (11 h) was selected as the best 
formulation. To enhance the drug release from F8, HPC and CMC were 
tried (1%, w/w) as release modifiers (F10 and F11). Among these, the 
CMC showed no enhancement, rather decreased the drug release 
(table 1), hence, acted as a support matrix only, however, the HPC 
considerably enhanced the drug release (86.3%). The concentration of 
HPC was further enhanced (F12), the entrapment efficiency and 
release of drug increased from 2% HPC in formulation to 92.75 % and 
88.30 %, respectively. The formulation consisting of 3% HPC (F13), 
showed decreased entrapment and release similar observations have 
been reported by Iglesias et al. [10].  
Differential scanning calorimetry (DSC) 
The compatibility of theophylline and the polymer blend 
(alginate+sesbania gum+HPC) was checked using DSC. The 
thermograms have been shown in fig. 1. Theophylline exhibited a sharp 
endothermic peak at 269.21 °C, corresponding to its melting transition 
point (fig. 1a). The physical mixture of drug and polymer showed three 
endothermic transitions peaks at 122.94 °C, 269.04 °C and 295.62 °C 
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Fig. 1: DSC thermogram of (a) pure theophylline (b) Physical 
mixture of drug, alginate and sesbania gum (c) drug loaded 
microbeads 
Weaker melting endotherm of theophylline appeared because the 
polymers might have inhibited melting of some drug crystals [11]. 
However, the prepared formulation of microbeads did not show any 
endothermic peak close to the drug melting point (fig. 1c). It may be 
indicated that drug was uniformly dispersed at the molecular level 
of polymers. But the prepared formulation showed early broad 
endothermic peak at 103.39 °C, probably due to evaporation of 
water. Hence, it may be concluded that there was no interaction 
between drug and excipients. 
Evaluation of microbeads 
Micromeritic properties  
Particle size of formed beads was measure using optical microscopy 
fitted with stage micro meter, and their flow properties were 
determined. The data is presented in table 2 shows comparative 
micromeritic properties of F4, F8 and F12.  
 
Table 2: Micromeritic properties of various selected formulations 
Formulation 
Code 










F-4 865±0.75 0.228±0.01 0.251±0.15 1.10±0.45 9.16±0.08 
F-8 894±0.01 0.264±0.10 0.311±0.47 1.17±0.01 15.11±0.50 
F-12 908±0.03 0.292±0.07 0.367±0.64 1.23±0.01 20.43±1.01 
 
Table 3: Release kinetic analysis data of theophylline from prepared microbeads 
Formulation code Regression coefficient (r2) n Release mechanism 
 Zero Order First Order Higuchi Peppas   
F-4 0.805 0.911 0.956 0.946 0.877  Non-fickian diffusion 
F-8 0.824 0.924 0.947 0.935 0.819  Non-fickian diffusion 
F-12 0.831 0.900 0.968 0.987 0.830  Non-fickian diffusion 
 
The particle size analysis of the formulations revealed that the 
particle size of the microbeads increased with increasing polymer 
concentration. This may be due to the increased viscosity at a higher 
polymer concentration resulting in enhanced interfacial tension 
with diminished shearing efficiency. Similar observations have 
previously been reported in literature [12]. The Hausner’s ratio also 
increased with increasing polymer concentration, but was less than 
1.25 indicating good flow properties of microbeads [13]. Good flow 
properties of the formulations were also revealed by compressibility 
index which was 15.11 and 20.43 for F-8 and F-12 indicating 
excellent compressibility and packaging properties [14]. Hence the 
microbeads have an excellent flow characteristic which means they 
can be easily handled during capsule filling operations. 
  
 
Fig. 2: Swelling behavior of microbeads in 0.1 N HCl buffer 
 
Equilibrium swelling studies of microbeads 
Swelling behavior of polymeric beads is one of the major factors 
controlling the drug release from the beads. For this reason, the 
swelling behavior of beads (fig. 2) was evaluated in 0.1 N HCl buffer 
(pH 1.2). 
Maximum swelling of beads was noted at 6-7 h in the buffer after 
which erosion and breakdown took place resulting in decline in the 
index. Similar observations have been reported by Larson et al. [15]. 
Such behavior results from slow erosion of cross-linked microbeads 
due to a slight degradation of alginate backbone into smaller 
fragments [16].  
In vitro release kinetics 
To investigate the kinetics and mechanism of theophylline release 
from the polymer beads, the release data were fitted to zero, first 
order, Higuchi and Korsmeyer-Peppas models, as described in the 
methodology section. The regression coefficient of all the models 
was calculated for formulations selected for further modification 
during the study (F-4 and F-8) and finally selected formulation (F-
12). The data have been represented in table 3. 
According to the regression coefficients (R2), the in vitro release data 
was in favor of Higuchi-diffusion kinetics (F-4 and F-8) and 
Korsmeyer Peppas model (F-12). If “n” is 0.45 or less, the release 
mechanism follows Fickian diffusion, but here the values obtained 
are higher (0.45<n<0.89). Therefore mass transfer followed a non-
Fickian model (anomalous transport), where release is controlled by 
a combination of diffusion and polymer relaxation. Thus, selected 
formulations delivered their active ingredient by coupled diffusion 
and erosion [17]. This erosion of the micro beads was confirmed 
using Scanning Electron Microscope (SEM). It was evident from the 
SEM pictures (fig. 3) that the micro beads of hetero-polymer eroded 
during delivery of theophylline.  
Mucoadhesivity testing 
The muco-adhesiveness of the prepared formulations was checked, 
as described in the methodology section and the data is presented in 
fig. 4. All the polymers used in the formulation development were 
having mucoadhesive property, hence, % bioadhesion increased as 
other polymers were mixed in sodium alginate. 
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(A) (B) (C) 
Fig. 3: Outer surface morphology of: (A) intact micro bead before dissolution; (B) Micro bead after 6h of dissolution; (C) Micro bead after 
11h of dissolution 
 
 
Fig. 4: Mucoadhesiveness of prepared formulations (F4, F8 and 
F12) 
 
Maximum bioadhesion was shown by F12, where 3 polymers were 
used. This result suggested that the developed formulation has good 
bioadhesiveness which is desired for extended release formulations 
so that they do not expel from GIT before complete drug release.  
CONCLUSION 
The use of naturally occurring polysaccharides, especially sodium 
alginate, functioning as biopolymers has been successfully used for 
sustained released hydrogel formulations. The entrapment and 
sustained release of the drug from alginates beads can further be 
improved by using other copolymers. In the present study, the sesbania 
gum and HPC were used as copolymers which enhanced entrapment 
efficiency, maximum drug release from the beads at extended time. Also 
it showed better adhesion to gastric mucosa, which is desired for 
extended release formulations. The developed formulation may be 
successfully used for sustained delivery of theophylline.  
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